Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C

Table 1 Characteristics of patients

	n	Male/female	Age (yr)	ALT (U/L)	AST (U/L)	Alkaline phosphatase (U/L)	Bilirubin (µmol/L)
CHC	100	52/48	42.08 ± 3	108.7 ± 10.12	75.6 ± 8.76	141.7 ± 6.78	18.9 ± 2.42
Control	30	16/14	40.79 ± 2	21.3 ± 1.92	18.5 ± 1.73	136.4 ± 6.56	13.8 ± 1.76